coronary artery disease
- Access DeniedWhat Is the Clinical Relevance of the Discordance Between Fractional Flow Reserve and Coronary Flow Reserve?Bon-Kwon KooJACC: Cardiovascular Interventions
- Access DeniedImpact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study)Insights From Coronary Angiogram and Electrogram AnalysisLuis Nombela-Franco, Ignacio Fernández-Lozano, et al.JACC: Cardiovascular Interventions
- Access DeniedSurvival and Chronic Total Occlusion Percutaneous Coronary InterventionThe Never-Ending Debate ContinuesJ. Aaron GranthamJACC: Cardiovascular Interventions
- Access DeniedContemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total OcclusionsInsights From the VA CART ProgramThomas T. Tsai, Emmanouil S. Brilakis, et al.JACC: Cardiovascular Interventions
- Access DeniedDiagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial IschemiaValidation With 13N-Ammonia Positron Emission TomographyDoyeon Hwang, Bon-Kwon Koo, et al.JACC: Cardiovascular Interventions
- Access DeniedAssessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary InterventionA Report From the NCDRJacob A. Doll, Sunil V. Rao, et al.JACC: Cardiovascular Interventions
- Access DeniedAcute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular AneurysmPartha Sardar, Frederick G.P. Welt, et al.JACC: Cardiovascular Interventions
- Access DeniedProximal Left Anterior Descending Coronary Artery PCIIs it No Longer the Last Lesion Standing?Elizabeth M. HolperJACC: Cardiovascular Interventions
- Access DeniedLong-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT TrialAriel Roguin, William Wijns, et al.JACC: Cardiovascular Interventions
- Access DeniedEverolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery DiseaseA Matched ComparisonJens Wiebe, Holger M. Nef, et al.JACC: Cardiovascular Interventions
Pages
Advertisement